Safety and efficacy of azacitidine in the treatment of elderly patients with myelodysplastic syndrome

por Ritchie, Ellen K
Publicado 2012

Hematopoietic fitness of JAK2(V617F) myeloproliferative neoplasms is linked to clinical outcome

por Abu-Zeinah, Ghaith, Di Giandomenico, Silvana, Choi, Daniel, Cruz, Tatiana, Erdos, Katie, Taylor, Elwood, Ritchie, Ellen K., Silver, Richard T., Scandura, Joseph M.
Publicado 2022

Geriatric assessment for older adults receiving less-intensive therapy for acute myeloid leukemia: report of CALGB 361101

por Ritchie, Ellen K., Klepin, Heidi D., Storrick, Elizabeth, Major, Brittny, Le-Rademacher, Jennifer, Wadleigh, Martha, Walker, Alison, Larson, Richard A., Roboz, Gail J.
Publicado 2022

Phase I trial of plerixafor combined with decitabine in newly diagnosed older patients with acute myeloid leukemia

por Roboz, Gail J., Ritchie, Ellen K., Dault, Yulia, Lam, Linda, Marshall, Danielle C., Cruz, Nicole M., Hsu, Hsiao-Ting C., Hassane, Duane C., Christos, Paul J., Ippoliti, Cindy, Scandura, Joseph M., Guzman, Monica L.
Publicado 2018

Pediatric-inspired chemotherapy incorporating pegaspargase is safe and results in high rates of minimal residual disease negativity in adults up to the age of 60 years with Philade...

por Geyer, Mark B., Ritchie, Ellen K., Rao, Arati V., Vemuri, Shreya, Flynn, Jessica, Hsu, Meier, Devlin, Sean M., Roshal, Mikhail, Gao, Qi, Shukla, Madhulika, Salcedo, Jose M., Maslak, Peter, Tallman, Martin S., Douer, Dan, Park, Jae H.
Publicado 2020

Clinical and molecular epidemiology of human rhinovirus infections in patients with hematologic malignancy

por Jacobs, Samantha E., Lamson, Daryl M., Soave, Rosemary, Guzman, Brigitte Huertas, Shore, Tsiporah B., Ritchie, Ellen K., Zappetti, Dana, Satlin, Michael J., Leonard, John P., Besien, Koen van, Schuetz, Audrey N., Jenkins, Stephen G., George, Kirsten St., Walsh, Thomas J.
Publicado 2015

Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AML

por Lopez, Amanda, Patel, Sanjay, Geyer, Julia T., Racchumi, Joelle, Chadburn, Amy, Simonson, Paul, Ouseph, Madhu M., Inghirami, Giorgio, Mencia-Trinchant, Nuria, Guzman, Monica L., Gomez-Arteaga, Alexandra, Lee, Sangmin, Desai, Pinkal, Ritchie, Ellen K., Roboz, Gail J., Tam, Wayne, Kluk, Michael J.
Publicado 2021

Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and Efficacy

por Harrison, Claire N., Garcia, Jacqueline S., Somervaille, Tim C.P., Foran, James M., Verstovsek, Srdan, Jamieson, Catriona, Mesa, Ruben, Ritchie, Ellen K., Tantravahi, Srinivas K., Vachhani, Pankit, O'Connell, Casey L., Komrokji, Rami S., Harb, Jason, Hutti, Jessica E., Holes, Leanne, Masud, Abdullah A., Nuthalapati, Silpa, Potluri, Jalaja, Pemmaraju, Naveen
Publicado 2022

Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia

por Roboz, Gail J., Kantarjian, Hagop M., Yee, Karen W. L., Kropf, Patricia L., O'Connell, Casey L., Griffiths, Elizabeth A., Stock, Wendy, Daver, Naval G., Jabbour, Elias, Ritchie, Ellen K., Walsh, Katherine J., Rizzieri, David, Lunin, Scott D., Curio, Tania, Chung, Woonbok, Hao, Yong, Lowder, James N., Azab, Mohammad, Issa, Jean‐Pierre J.
Publicado 2017

Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia

por Atallah, Ehab, Schiffer, Charles A., Weinfurt, Kevin P., Zhang, Mei-Jie, Radich, Jerald P., Oehler, Vivian G., Pinilla-Ibarz, Javier, Deininger, Michael W. N., Lin, Li, Larson, Richard A., Mauro, Michael J., Moore, Joseph O., Ritchie, Ellen K., Shah, Neil P., Silver, Richard T., Wadleigh, Martha, Cortes, Jorge, Thompson, James, Guhl, Jessica, Horowitz, Mary M., Flynn, Kathryn E.
Publicado 2018

CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemi...

por Lancet, Jeffrey E., Uy, Geoffrey L., Cortes, Jorge E., Newell, Laura F., Lin, Tara L., Ritchie, Ellen K., Stuart, Robert K., Strickland, Stephen A., Hogge, Donna, Solomon, Scott R., Stone, Richard M., Bixby, Dale L., Kolitz, Jonathan E., Schiller, Gary J., Wieduwilt, Matthew J., Ryan, Daniel H., Hoering, Antje, Banerjee, Kamalika, Chiarella, Michael, Louie, Arthur C., Medeiros, Bruno C.
Publicado 2018

Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, mult...

por Stahl, Maximilian, Shallis, Rory M., Wei, Wei, Montesinos, Pau, Lengline, Etienne, Neukirchen, Judith, Bhatt, Vijaya R., Sekeres, Mikkael A., Fathi, Amir T., Konig, Heiko, Luger, Selina, Khan, Irum, Roboz, Gail J., Cluzeau, Thomas, Martínez-Cuadron, David, Raffoux, Emmanuel, Germing, Ulrich, Umakanthan, Jayadev Manikkam, Mukherjee, Sudipto, Brunner, Andrew M., Miller, Adam, McMahon, Christine M., Ritchie, Ellen K., Rodríguez-Veiga, Rebeca, Itzykson, Raphaël, Boluda, Blanca, Rabian, Florence, Tormo, Mar, Cruz, Evelyn Acuña, Rabinovich, Emma, Yoo, Brendan, Cano, Isabel, Podoltsev, Nikolai A, Bewersdorf, Jan Philipp, Gore, Steven, Zeidan, Amer M.
Publicado 2020